USPTO serial 90361889
BIOLOGY TO BARCODES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 31, 2024
- Examiner
- GOODWIN, KATRINA JOYE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIOLOGY TO BARCODES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leigh AUGUSTINE
Leigh AUGUSTINE EIP US LLP4600 S. Syracuse Street, 9th FloorDenver, CO 80237United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Agricultural testing for nucleic acid sequences and gene expression; Analysis of water quality; Bacteriological research; Bacteriological research and testing; Biochemical research and analysis; Biochemical research and development; Biological research; Biological research and analysis; Biotechnology research; Blood analysis services; Chemical analysis; Chemical analysis services; Chemical research; Chemical research and analysis; Chemical research services; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of evaluating the presence of nucleic acids, antigens, gene expression, tissue structures, and radiation exposure; Computer programming and software design; Computer programming consultancy in the field of biotechnology, nucleic acid detection, agricultural, and toxicology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Detection of contaminants in water; Detection of contaminants in waste water; Developing and updating computer software; Developing computer software; Developing customized software for others; Development of new technology for others in the field of biotechnology, nucleic acid detection, agricultural, and toxicology; Diagnostic services in the field of biotechnology, nucleic acid detection, agricultural, and toxicology; DNA analysis services for scientific research purposes; DNA analysis services to determine paternity; DNA screening for scientific research purposes; Dosimetry monitoring services; Drug discovery services; Food safety testing and consultation related thereto; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genotyping services for research or analysis purposes; Laboratory analysis in the field of biotechnology, nucleic acid detection, agricultural, and toxicology; Laboratory research in the field of biotechnology, nucleic acid detection, agricultural, and toxicology; Medical laboratory services; Medical research services; Medical research services in the field of cancer; Monitoring of water quality; Monitoring of DNA, RNA, proteins, and viruses for scientific research purposes; Providing a website for the electronic storage of nucleotide sequences, single-nucleotide polymorphisms, and sample information; Providing information in the field of plant genetics research resources; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Providing scientific information in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Rental of application software; Rental of computer hardware; Rental of computer hardware and computer software; Rental of computer software; Rental of computer software and programs; Rental of computers; Rental of computers and software; Rental of laboratory apparatus and instruments; Rental of laboratory robots; Research and development and consultation related thereto in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Research and development in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Research and development of technology in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Research services in the field of forensic science, namely, analysis, detection and isolation of biological substances in forensic samples; Scientific and technological services, namely, detection of the presence of nucleic acids and antigens, and modifications thereof, gene expression, tissue structures, and radiation exposure in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Scientific research; Scientific research and development; Scientific research consulting in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Scientific study and research in the field(s) of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Software as a service (SAAS) services featuring software for detecting labeled molecules and analyzing genetic data, aligning sequences, controlling laboratory equipment, bioinformatics, expression profiling, and metabolic pathways; Software as a service (SAAS) services, namely, hosting software for use by others for use detecting labeled molecules and analyzing genetic data, aligning sequences, controlling laboratory equipment, bioinformatics, expression profiling, and metabolic pathways; Technology advisory services related to biotechnology, nucleic acid detection, agricultural, and toxicology; Testing of chemicals; Testing of filters; Testing, inspection or research on agriculture, livestock breeding or fisheries; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Toxicology services; Water analysis | ACTIVE | Mar 30, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioSpyder Technologies, Inc.
- Other trademarks owned by BioSpyder Technologies, Inc.
- Other trademarks owned by BioSpyder Technologies, Inc.
- Other trademarks in Class 042
- Similar marks named BIOLOGY TO BARCODES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 31, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 31, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 10, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 10, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 4, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 4, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 4, 2024 | ALIE | ASSIGNED TO LIE | — |
| Oct 21, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 18, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 18, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 19, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2024 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 14, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 24, 2024 | IUAF | USE AMENDMENT FILED | — |
| Jan 24, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 5, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 3, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 3, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 3, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 2, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 31, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 31, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 31, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 2, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 29, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 29, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 29, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 5, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 3, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 3, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 3, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 13, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 13, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 3, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 8, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 8, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 19, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 26, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 11, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 9, 2020 | NWAP | NEW APPLICATION ENTERED | — |